mRNA |
CIL70 |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.08 |
mRNA |
FQI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.08 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.08 |
mRNA |
etomoxir |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.08 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.08 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.09 |
mRNA |
PF-184 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.09 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.09 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.09 |
mRNA |
Erlotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.09 |